An Open-Label, 2-Way Crossover Study To Investigate The Pharmacokinetics, Safety And Tolerability Of IV CP-70429 And Oral PF-03709270 In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function.
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2016
At a glance
- Drugs Sulopenem; Sulopenem
- Indications Bacterial infections
- Focus Pharmacokinetics
- 28 Apr 2010 Actual number of patients changed from 21 to 29 as reported by ClinicalTrials.gov record.
- 28 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Feb 2010 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.